Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Lung cancer symbols : A save search
Agilent PD-L1 IHC 22C3 pharmDx Expands CE-IVD mark in Non-small Cell Lung Cancer (NSCLC)
Published: 2021-07-20 (Crawled : 20:00) - biospace.com/
A | $133.91 0.89% 0.0% 850K
|
Health Technology
|
| O: 0.59%
H: 1.89%
C: 0.57%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.29%
H: 1.02%
C: 0.78%
lung cancer cancer
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer
Published: 2021-06-04 (Crawled : 13:00) - biospace.com/
A | $133.91 0.89% 0.0% 850K
|
Health Technology
|
| O: 0.98%
H: 0.51%
C: 0.15%
lung cancer therapy cancer
Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)
Published: 2021-02-22 (Crawled : 22:00) - biospace.com/
A | $133.91 0.89% 0.0% 850K
|
Health Technology
|
| O: -0.73%
H: 0.17%
C: -1.95%
fda lung cancer fda approval cancer approval
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.